{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Kidney&page=36", "query": { "condition": "Kidney", "page": 36 }, "page_size": 10 }, "pagination": { "page": 36, "page_size": 10, "total_count": 6440, "total_pages": 644, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Kidney&page=37&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Kidney&page=35&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-31T17:45:02.321Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06299163", "title": "NM32-2668 in Adult Patients With Selected Advanced Solid Tumors", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Ovarian Carcinoma", "Fallopian Tube Carcinoma", "Peritoneal Carcinoma", "Endometrial Cancer", "Adenocarcinoma of Lung", "Triple Negative Breast Cancer", "Liposarcoma", "Leiomyosarcoma", "Mesothelioma, Malignant", "Adenocarcinoma - Gastroesophageal Junction (GEJ)", "Adenocarcinoma of the Stomach", "Melanoma, Malignant", "Renal Cell Carcinoma" ], "interventions": [ { "name": "NM32-2668", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Numab Therapeutics AG", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 11, "start_date": "2024-05-01", "completion_date": "2025-04-18", "has_results": false, "last_update_posted_date": "2025-07-23", "last_synced_at": "2026-10-31T17:45:02.321Z", "location_count": 11, "location_summary": "Birmingham, Alabama • Los Angeles, California • Chicago, Illinois + 8 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT06299163" }, { "nct_id": "NCT07688187", "title": "A Study of Theranostic Pair PD-32766D/T in Participants With Carbonic Anhydrase IX Positive Clear Cell Renal Cell Carcinoma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Clear Cell Renal Cell Carcinoma" ], "interventions": [ { "name": "PD-32766D (a Copper-64 [64Cu] labeled peptide)", "type": "DRUG" }, { "name": "PD-32766T (an Actinium-225 [225Ac] labeled peptide)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "PeptiDream Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2026-07-07", "completion_date": "2029-06", "has_results": false, "last_update_posted_date": "2026-09-18", "last_synced_at": "2026-10-31T17:45:02.321Z", "location_count": 1, "location_summary": "Omaha, Nebraska", "locations": [ { "city": "Omaha", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT07688187" }, { "nct_id": "NCT03180619", "title": "Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) From Tenofovir Disoproxil Fumarate (TDF) and/or Other Oral Antiviral Treatment (OAV)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Hepatitis B" ], "interventions": [ { "name": "TAF", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 124, "start_date": "2017-06-29", "completion_date": "2020-09-04", "has_results": true, "last_update_posted_date": "2021-09-27", "last_synced_at": "2026-10-31T17:45:02.321Z", "location_count": 4, "location_summary": "Los Angeles, California • San Jose, California • Detroit, Michigan + 1 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Jose", "state": "California" }, { "city": "Detroit", "state": "Michigan" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT03180619" }, { "nct_id": "NCT06557265", "title": "A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Lupus Nephritis", "Primary Membranous Nephropathy" ], "interventions": [ { "name": "NKX019", "type": "DRUG" }, { "name": "Fludarabine, Cyclophosphamide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Nkarta, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 120, "start_date": "2024-06-13", "completion_date": "2027-04", "has_results": false, "last_update_posted_date": "2026-06-04", "last_synced_at": "2026-10-31T17:45:02.321Z", "location_count": 17, "location_summary": "Little Rock, Arkansas • Tustin, California • Gainesville, Florida + 14 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Tustin", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Plantation", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06557265" }, { "nct_id": "NCT02108600", "title": "Tocilizumab for Renal Graft Inflammation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Late Complication From Kidney Transplant" ], "interventions": [ { "name": "Tocilizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Flavio Vincenti", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 33, "start_date": "2014-06", "completion_date": "2018-12-16", "has_results": true, "last_update_posted_date": "2021-03-09", "last_synced_at": "2026-10-31T17:45:02.321Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02108600" }, { "nct_id": "NCT00141765", "title": "Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Wilms Tumor", "Fibrosarcoma", "Carcinoma, Round Cell", "Nasopharyngeal Cancer", "Brain Tumor, Recurrent" ], "interventions": [ { "name": "Myeloablative Chemotherapy", "type": "PROCEDURE" }, { "name": "Stem Cell Rescue", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "University of Michigan Rogel Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "21 Years", "sex": "ALL", "summary": "Up to 21 Years" }, "enrollment_count": 25, "start_date": "1997-01", "completion_date": "2010-02", "has_results": true, "last_update_posted_date": "2014-06-20", "last_synced_at": "2026-10-31T17:45:02.321Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT00141765" }, { "nct_id": "NCT00325507", "title": "Safety and Biological Activity of TroVax® Vaccine Given With IL-2 in Renal Cell Carcinoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Carcinoma, Renal Cell" ], "interventions": [ { "name": "TroVax", "type": "BIOLOGICAL" }, { "name": "IL-2", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Oxford BioMedica", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 25, "start_date": "2005-11", "completion_date": "2008-07", "has_results": false, "last_update_posted_date": "2020-10-19", "last_synced_at": "2026-10-31T17:45:02.321Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00325507" }, { "nct_id": "NCT06278207", "title": "An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Chronic Kidney Disease", "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "Finerenone (BAY 94-8862)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50000, "start_date": "2024-05-15", "completion_date": "2026-09-30", "has_results": false, "last_update_posted_date": "2026-06-18", "last_synced_at": "2026-10-31T17:45:02.321Z", "location_count": 1, "location_summary": "Multiple Locations, New Jersey", "locations": [ { "city": "Multiple Locations", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT06278207" }, { "nct_id": "NCT00811863", "title": "Evaluation of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Following OptiMARK Injection", "overall_status": "WITHDRAWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Nephrogenic Systemic Fibrosis", "Renal Insufficiency" ], "interventions": [], "intervention_types": [], "sponsor": "Guerbet", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 0, "start_date": "2009-02", "completion_date": "2012-05-17", "has_results": false, "last_update_posted_date": "2017-08-02", "last_synced_at": "2026-10-31T17:45:02.321Z", "location_count": 1, "location_summary": "Youngstown, Ohio", "locations": [ { "city": "Youngstown", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00811863" }, { "nct_id": "NCT05874921", "title": "uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Urothelial Carcinoma", "Urothelial Carcinoma Recurrent", "Urothelial Carcinoma Ureter", "Urothelial Carcinoma Ureter Recurrent", "Urothelial Cancer of Renal Pelvis", "Urothelial Carcinoma of the Renal Pelvis and Ureter", "Carcinoma, Transitional Cell", "Transitional Cell Carcinoma of Renal Pelvis" ], "interventions": [ { "name": "Jelmyto (mitomycin) for pyelocalyceal solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "UroGen Pharma Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 450, "start_date": "2023-11-17", "completion_date": "2030-10", "has_results": false, "last_update_posted_date": "2026-09-29", "last_synced_at": "2026-10-31T17:45:02.321Z", "location_count": 22, "location_summary": "Santa Monica, California • Gainesville, Florida • Miami, Florida + 17 more", "locations": [ { "city": "Santa Monica", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT05874921" } ] }